Mynosys Cellular Devices Inc. is a medical device company providing innovative solutions to help surgeons achieve excellence in cataract surgery.  Our product Zepto®, is a unique micro-fabricated instrument that provides unmatched precision during surgery on a millisecond time scale to tackle routine and challenging cases with confidence and efficiency.  Zepto technology is patented worldwide and is available in selected markets through local distributors.

ZEPTO by Mynosys Cellular Devices Inc.

 

NEWS

24 Jan Is it Possible to Decrease Capsular Fibrosis Using Zepto PCS? In early 2016, Dr. Kevin Waltz participated in initial trials of the ... read more ›
15 Oct Visco Chirurgia Publishes Zepto Clinical Trial Results Zepto receives positive results in clinical trial in Italy, as ... read more ›
10 Sep Healio News: Automated Zepto Capsulotomy Has Advantages in Premium Procedures The Zepto capsulotomy system offers surgeons the opportunity to ... read more ›

FEATURED VIDEO